297 related articles for article (PubMed ID: 29770597)
1. Comparison and discussion of the treatment guidelines for small cell lung cancer.
Zhao H; Ren D; Liu H; Chen J
Thorac Cancer; 2018 Jul; 9(7):769-774. PubMed ID: 29770597
[TBL] [Abstract][Full Text] [Related]
2. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.
Horn L; Reck M; Spigel DR
Oncologist; 2016 Aug; 21(8):910-21. PubMed ID: 27354668
[TBL] [Abstract][Full Text] [Related]
3. Novel Therapeutic Options for Small Cell Lung Cancer.
Canova S; Trevisan B; Abbate MI; Colonese F; Sala L; Baggi A; Bianchi SP; D'Agostino A; Cortinovis DL
Curr Oncol Rep; 2023 Nov; 25(11):1277-1294. PubMed ID: 37870696
[TBL] [Abstract][Full Text] [Related]
4. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
Ragavan M; Das M
Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
[TBL] [Abstract][Full Text] [Related]
5. SCLC-State of the Art and What Does the Future Have in Store?
Kahnert K; Kauffmann-Guerrero D; Huber RM
Clin Lung Cancer; 2016 Sep; 17(5):325-333. PubMed ID: 27397481
[TBL] [Abstract][Full Text] [Related]
6. Targeted Therapy and Immune Therapy for Small Cell Lung Cancer.
Gadgeel SM
Curr Treat Options Oncol; 2018 Sep; 19(11):53. PubMed ID: 30203184
[TBL] [Abstract][Full Text] [Related]
7. Use of Immunotherapy in Extensive-Stage Small Cell Lung Cancer.
Konala VM; Madhira BR; Ashraf S; Graziano S
Oncology; 2020; 98(11):749-754. PubMed ID: 32663833
[TBL] [Abstract][Full Text] [Related]
8. Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer.
Yu L; Lai Q; Gou L; Feng J; Yang J
J Drug Target; 2021 Jan; 29(1):1-11. PubMed ID: 32700566
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of
Small Cell Lung Cancer].
Huang B; Duan Y
Zhongguo Fei Ai Za Zhi; 2019 Apr; 22(4):239-244. PubMed ID: 31014443
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential.
Hu J; Wang Y; Zhang Y; Yu Y; Chen H; Liu K; Yao M; Wang K; Gu W; Shou T
Cancer Med; 2019 Aug; 8(9):4338-4347. PubMed ID: 31199602
[TBL] [Abstract][Full Text] [Related]
11. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Ganti AKP; Loo BW; Bassetti M; Blakely C; Chiang A; D'Amico TA; D'Avella C; Dowlati A; Downey RJ; Edelman M; Florsheim C; Gold KA; Goldman JW; Grecula JC; Hann C; Iams W; Iyengar P; Kelly K; Khalil M; Koczywas M; Merritt RE; Mohindra N; Molina J; Moran C; Pokharel S; Puri S; Qin A; Rusthoven C; Sands J; Santana-Davila R; Shafique M; Waqar SN; Gregory KM; Hughes M
J Natl Compr Canc Netw; 2021 Dec; 19(12):1441-1464. PubMed ID: 34902832
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is Hope.
Lehman JM; Gwin ME; Massion PP
Curr Oncol Rep; 2017 Jul; 19(7):49. PubMed ID: 28643173
[TBL] [Abstract][Full Text] [Related]
13. [Highlights of PAPR Inhibitors in Small Cell Lung Cancer].
Zhang S; Liu J; Yang C; Zhang L; Li S; Bao H; Cheng Y
Zhongguo Fei Ai Za Zhi; 2020 Sep; 23(9):806-810. PubMed ID: 32752582
[TBL] [Abstract][Full Text] [Related]
14. Development of targeted therapy and immunotherapy for treatment of small cell lung cancer.
Saito M; Shiraishi K; Goto A; Suzuki H; Kohno T; Kono K
Jpn J Clin Oncol; 2018 Jul; 48(7):603-608. PubMed ID: 29762727
[TBL] [Abstract][Full Text] [Related]
15. Small-Cell Lung Cancer-An Update on Targeted and Immunotherapies.
McNamee N; da Silva IP; Nagrial A; Gao B
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175833
[TBL] [Abstract][Full Text] [Related]
16. Small cell lung cancer; recent advances of its biology and therapeutic perspective.
Hayashi R; Inomata M
Respir Investig; 2022 Mar; 60(2):197-204. PubMed ID: 34896039
[TBL] [Abstract][Full Text] [Related]
17. Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
Ogino A; Choi J; Lin M; Wilkens MK; Calles A; Xu M; Adeni AE; Chambers ES; Capelletti M; Butaney M; Gray NS; Gokhale PC; Palakurthi S; Kirschmeier P; Oxnard GR; Sholl LM; Jänne PA
Mol Oncol; 2021 Jan; 15(1):27-42. PubMed ID: 32191822
[TBL] [Abstract][Full Text] [Related]
18. Second-line treatments of small-cell lung cancers.
Baize N; Monnet I; Greillier L; Quere G; Kerjouan M; Janicot H; Vergnenegre A; Auliac JB; Chouaid C
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1033-1043. PubMed ID: 28849951
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy or chemo-immunotherapy as first-line treatment for extensive-stage small-cell lung cancer: a meta-analysis.
Chen CY; Chen WC; Hung CM; Wei YF
Immunotherapy; 2021 Oct; 13(14):1165-1177. PubMed ID: 34261336
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges.
Pavan A; Attili I; Pasello G; Guarneri V; Conte PF; Bonanno L
J Immunother Cancer; 2019 Aug; 7(1):205. PubMed ID: 31383005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
